Skip to search.
 All Ordinaries Up 0.64%

Neostem, Inc. (NBS)

-NasdaqCM
3.01 21 Apr 06:00
|Pre-Market : 3.05 Up 0.05 (1.67%) 22:07 - Nasdaq Real-Time Price
Add to Portfolio
Prev Close:3.01
Open:N/A
Bid:2.90 x 2600
Ask:3.04 x 200
1y Target Est:18.17
Beta:0.59
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:2.34 - 7.23
Volume:0
Avg Vol (3m):336,845
Market Cap:115.76M
P/E (ttm):N/A
EPS (ttm):-1.68
Div & Yield:0.06 (1.00%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NBS 0.00%115.76M
BAX38.18B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):6.45
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.53
Quarterly EPS Est (Mar-15) :-0.36
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.03

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NeoStem, Inc., a clinical-stage biopharmaceutical company, develops cell based therapeutics in the United States. It is developing NBS20, a targeted cancer immunotherapy product that is in Phase III clinical trials for the treatment of metastatic ... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback